Instrument Inactif

Communiqués Optimer Pharmaceuticals, Inc.

Actions

US68401H1041

Produits pharmaceutiques

Cours en clôture Nasdaq
- ^USD	-

31/07/13

USA-Les valeurs à suivre à Wall Street (actualisé)

Communiqués

04/10/13	Optimer Pharmaceuticals, Inc. : Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc.	PR
29/08/13	Optimer Pharmaceuticals, Inc. : Today's Research: Inovio Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., Sequenom Inc. and Optimer Pharmaceuticals Inc.	PR
13/08/13	Optimer Pharmaceuticals, Inc. : Harwood Feffer LLP Announces Investigation of Optimer Pharmaceuticals, Inc.	PR
12/08/13	Optimer Pharmaceuticals, Inc. : SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Optimer Pharmaceuticals, Inc.	BU
12/08/13	Optimer Pharmaceuticals, Inc. : Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer	PR
05/08/13	Optimer Pharmaceuticals, Inc. : SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Optimer Pharmaceuticals, Inc. - OPTR	PR
01/08/13	Optimer Pharmaceuticals, Inc. : OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.	PR
01/08/13	Optimer Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Optimer Pharmaceuticals, Inc.	PR
01/08/13	Optimer Pharmaceuticals, Inc. : Optimer Reports Second Quarter 2013 Financial Results	PR
01/08/13	Optimer Pharmaceuticals, Inc. : Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Optimer Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Cubist Pharmaceuticals, Inc.	BU
01/08/13	Optimer Pharmaceuticals, Inc. : OPTIMER PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Optimer Pharmaceuticals, Inc. Following Announcement of Proposed Sale of Company to Cubist Pharmaceuticals, Inc.	BU
31/07/13	Optimer Pharmaceuticals, Inc. : OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.	BU
31/07/13	Optimer Pharmaceuticals, Inc. : Milberg Announces Investigation of Unfair Low Price In Cubist's Acquisition of Optimer	BU
31/07/13	Optimer Pharmaceuticals, Inc. : SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Optimer Pharmaceuticals, Inc. - OPTR	PR
31/07/13	Optimer Pharmaceuticals, Inc. : Rigrodsky & Long, P.A. Announces Investigation Of Optimer Pharmaceuticals, Inc. Buyout	BU
31/07/13	Optimer Pharmaceuticals, Inc. : Finkelstein Thompson LLP Announces Investigation of Optimer Pharmaceuticals, Inc. Buyout	BU
31/07/13	Optimer Pharmaceuticals, Inc. : Optimer Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Sale of Optimer to Cubist	BU
31/07/13	Optimer Pharmaceuticals, Inc. : Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Optimer Pharmaceuticals Proposed Acquisition by Cubist Pharmaceuticals, Inc.	BU
31/07/13	Optimer Pharmaceuticals, Inc. : SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with the Sale of the Company to Cubist Pharmaceuticals, Inc.	BU
30/07/13	Optimer Pharmaceuticals, Inc. : Cubist Pharmaceuticals to Acquire Optimer Pharmaceuticals	BU
25/07/13	Optimer Pharmaceuticals, Inc. : Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2013 Financial Results	PR
24/07/13	Optimer Pharmaceuticals, Inc. : Today's Technical View: Inovio Pharma, Sequenom, Onyx Pharma, and Optimer Pharma	PR
20/06/13	Optimer Pharmaceuticals, Inc. : Today's Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma	PR
13/05/13	Optimer Pharmaceuticals, Inc. : Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer	PR
09/05/13	Optimer Pharmaceuticals, Inc. : Optimer Reports First Quarter 2013 Financial Results	PR